A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa

Competing Interest Statement

The authors have declared no competing interest.

Clinical Protocols

https://github.com/krisp-kwazulu-natal/africa-covid19-genomics

Funding Statement

South Africa data was funded by the Department of Science and Innovation and the South African Medical Research Council (SAMRC). Ministry of Higher Education and Scientific Research and Ministry of Health of the Republic of Tunisia. Project ADAGE PRFCOV19 GP2 (2020 to 2022), which includes 40 researchers from the Center of Biotechnology of Sfax, the University of Sfax, the University of Monastir, the University Hospital Hedi Chaker of Sfax, the Military Hospital of Tunis, and Dacima Consulting. MRC/UVRI & London School of Hygiene and Tropical Medicine, Entebbe, Uganda was funded by the UK Medical Research Council (MRC/UKRI) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement (grant agreement number NC PC 19060) and is also part of the EDCTP2 programme supported by the European Union. The UMIC high performance computer was supported by MRC (grant number MC EX MR/L016273/1) to PK. A.R. acknowledges the support of the Wellcome Trust (Collaborators Award 206298/Z/17/Z ARTIC network) and the European Research Council (grant agreement no. 725422 ReservoirDOCS). The study is additionally funded by the Wellcome, DFID Wellcome Epidemic Preparedness Coronavirus (AFRICO19, grant agreement number 220977/Z/20/Z) awarded to MC. Work from Quadram Institute Bioscience was funded by The Biotechnology and Biological Sciences Research Council Institute Strategic Programme Microbes in the Food Chain BB/R012504/1 and its constituent projects BBS/E/F/000PR10348, BBS/E/F/000PR10349, BBS/E/F/000PR10351, and BBS/E/F/000PR10352 and by the Quadram Institute Bioscience BBSRC funded Core Capability Grant (project number BB/CCG1860/1). Sequences generated in Zambia through PATH were funded by the Bill & Melinda Gates Foundation. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. Sequencing efforts at KEMRI site in Kenya was supported by the National Institute for Health Research (NIHR) (project references 17/63/82 and 16/136/33), using UK aid from the UK Government to support global health research, and the UK Foreign, Commonwealth and Development Office and Wellcome Trust (grant# 102975; 220985). The views expressed in this publication are those of the authors and not necessarily those of any of the institutions they represent. Sequencing efforts from Morocco have been supported by Academie Hassan II of Science and Technology, Morocco. Funding for sequencing in Cote d'Ivoire, Burkina Faso and part of the sequencing in the Democratic Republic of the Congo was granted by the German Federal Ministry of Education and Research (BMBF).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The project was approved by University of KwaZulu-Natal Biomedical Research Ethics Committee. Protocol reference number: BREC/00001195/2020. Project title: COVID-19 transmission and natural history in KwaZulu-Natal, South Africa: Epidemiological Investigation to Guide Prevention and Clinical Care. Ethics ammendment was approved to expand the analysis of public and anonymized data from Africa. This project was also approved by University of the Witwatersrand Human Research Ethics Committee. Clearance certificate number: M180832. Project title: Surveillance for outpatient influenza-like illness and asymptomatic virus colonization in South Africa. Sequence data from the Western Cape was approved by the Stellenbosch University HREC Reference No: N20/04/008_COVID-19. Project Title: COVID-19: sequencing the virus from South African patients.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes